Paid Clinical Trials Georgia

Discover 1,810 paid clinical trials in Georgia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,810

A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)

Recruiting

PHASE2

Sponsor:

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA

Location:

Atlanta, Jacksonville, Charleston, Orlandoshow 49 more

Code:

NCT04945460

Conditions

Hypertension, Pulmonary

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Sotatercept 0.3 mg/kg

Placebo

Sotatercept 0.3 mg/kg escalating to 0.7 mg/kg

Hydroxyurea Optimization Through Precision Study

Recruiting

PHASE3

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Atlanta, Cincinnati, Columbus, Indianapolisshow 8 more

Code:

NCT03789591

Conditions

Sickle Cell Disease

Sickle Cell Anemia

Eligibility Criteria

Sex: All

Age: 6 - 21

Healthy Volunteers: Not accepted

Interventions

Hydroxyurea

Remedē System Therapy Study

Recruiting

Sponsor:

Respicardia, Inc.

Location:

Atlanta, Charlotte, Orlando, Winston-Salemshow 24 more

Code:

NCT03884660

Conditions

Central Sleep Apnea

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

remede System

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

Recruiting

Sponsor:

National Cancer Institute (NCI)

Location:

Augusta, Birmingham, Chapel Hill, Durhamshow 92 more

Code:

NCT02474160

Conditions

Hematopoietic and Lymphatic System Neoplasm

Malignant Solid Neoplasm

Metastatic Malignant Solid Neoplasm

Recurrent Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cytology Specimen Collection Procedure

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011)

Recruiting

PHASE1

PHASE2

Sponsor:

Merck Sharp & Dohme LLC

Location:

Marietta, Roanoke, Miami Beach

Code:

NCT06596694

Conditions

Gastrointestinal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Patritumab deruxtecan

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM

Recruiting

PHASE3

Sponsor:

Cytokinetics

Location:

Fayetteville, Atlanta, Charleston, Greenvilleshow 45 more

Code:

NCT06081894

Conditions

Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Aficamten

Placebo

Mucopolysaccharidosis I (MPS I) Registry

Recruiting

Sponsor:

Genzyme, a Sanofi Company

Location:

Decatur, Jacksonville, Gainesville, Greenvilleshow 62 more

Code:

NCT00144794

Conditions

Mucopolysaccharidosis I (MPS I)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Recruiting

PHASE2

Sponsor:

AstraZeneca

Location:

Gainesville, Chattanooga, Nashville, Stuartshow 18 more

Code:

NCT05061550

Conditions

Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Durvalumab

Oleclumab

Monalizumab

Dato-DXd

AZD0171

A Phase 2 Study of Vosoritide in Children with Idiopathic Short Stature

Recruiting

PHASE2

Sponsor:

BioMarin Pharmaceutical

Location:

Columbus, Pensacola, Buffalo, Bronxshow 4 more

Code:

NCT06382155

Conditions

Idiopathic Short Stature

Eligibility Criteria

Sex: All

Age: 3 - 10

Healthy Volunteers: Not accepted

Interventions

Vosoritide Injection

Human Growth Hormone

Placebo

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

Recruiting

PHASE2

Sponsor:

Takeda

Location:

Decatur, Atlanta, Greenville, Clearwatershow 21 more

Code:

NCT06254950

Conditions

Ulcerative Colitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

TAK-279

Placebo

Popular cities in Georgia

Atlanta Savannah